Related Experiment Video
Updated: Sep 24, 2025
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
10.3K
Acute bone damage through liver-bone axis induced by thioacetamide in rats
Xiaoli Jin1, Yang Li2, Jianghua Li3
1School of medical technology and information engineering, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
BMC Pharmacology & Toxicology
|May 7, 2022
Summary
Thioacetamide (TAA) induces liver damage in rats, evidenced by altered enzyme levels and fibrosis. TAA also causes significant bone damage, reducing bone density and increasing fracture risk, establishing it as a model for liver injury-related bone issues.
Area of Science:
- Biomedical Science
- Toxicology
- Animal Models
Background:
- Thioacetamide (TAA) is widely used in research to create animal models of liver injury.
- Liver damage can manifest in altered serum enzyme levels and histological changes.
- The bone damage induced by TAA is not well understood, necessitating further investigation.
Purpose of the Study:
- To establish a rat model that accurately reflects acute bone damage resulting from Thioacetamide (TAA) administration.
- To investigate the effects of TAA on bone health in Sprague-Dawley (SD) rats.
Main Methods:
- Sprague-Dawley (SD) rats were administered Thioacetamide (TAA) or saline intraperitoneally for one month.
- Serum biochemical tests were performed to analyze liver and bone markers.
- Masson staining assessed liver fibrosis, while micro-CT evaluated bone structure and density.
- Three-point bending tests measured the mechanical strength of rat hind limbs.
Main Results:
- TAA administration significantly increased liver enzymes (AST, ALT, ALP) and markers of kidney and bone metabolism (UA, TBA, UREA, CREA), while decreasing total protein, LDH, calcium, and phosphorus.
- Histological analysis revealed liver fibrosis and collagen deposition post-TAA treatment.
- Micro-CT scans showed reduced bone volume, surface area, and increased bone trabeculae separation in TAA-treated rats.
- TAA-induced bone damage resulted in decreased mechanical strength and increased susceptibility to fractures.
Conclusions:
- Thioacetamide (TAA) effectively induces liver damage in SD rats, confirmed by biochemical and histological changes.
- TAA treatment leads to reduced bone mineral density and compromised bone structure, causing bone injury.
- This study establishes TAA as a suitable model for studying bone metabolism abnormalities associated with liver injury.
